ÂÜÀòÂÒÂ×

Marcel Gremaud, CPA, has been Altamira Therapeutics’ Chief Financial Officer since November 2021. Mr. Gremaud has acquired more than 30 years’ experience in controlling and accounting in international pharma companies and start-ups. In 2001 he founded Gremaud GmbH, an audit and accounting company supporting companies in financial consolidation and accounting in accordance with IFRS or Swiss GAAP FER.